Nippon Shokubai News and Resources

Nippon Shokubai Co., Ltd. has announced plans to expand its manufacturing capacity for nucleic acid drug active pharmaceutical ingredients (APIs) by tenfold. The upgrade will involve installing a large-scale production line capable of producing several kilograms per batch and is expected